These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1624389)

  • 1. BSAC, third combined British Scandinavian Hellenic Conference, May 1991: immunotherapy of infectious disease.
    Evans TJ; Cohen J
    J Antimicrob Chemother; 1992 May; 29(5):495-8. PubMed ID: 1624389
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Kida Y
    JAMA; 2009 Nov; 302(18):1969; author reply 1969-70. PubMed ID: 19903916
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.
    Mitov IG; Terziiski DG
    Infection; 1991; 19(6):383-90. PubMed ID: 1816107
    [No Abstract]   [Full Text] [Related]  

  • 4. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
    Imbach P; Hässig A; Cottier H
    Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
    [No Abstract]   [Full Text] [Related]  

  • 5. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gram-negative septic shock with an immunoglobulin.
    Werdan K; Pilz G
    Crit Care Med; 1992 Sep; 20(9):1364-5. PubMed ID: 1521458
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
    Wortel CH; Dellinger RP
    Crit Care Med; 1993 Jan; 21(1):163-5. PubMed ID: 8420724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monoclonal antibodies in the treatment of septic shock].
    Trilla A; Alonso P
    Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950
    [No Abstract]   [Full Text] [Related]  

  • 10. Septic shock: pathogenesis and treatment.
    Bansal T; Mohan A; Sharma SK
    J Assoc Physicians India; 1996 Jun; 44(6):407-14. PubMed ID: 9282562
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-1 as a therapeutic agent in serious infections?
    van der Meer JW; Vogels MT
    Prog Clin Biol Res; 1991; 367():197-206. PubMed ID: 1924428
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapies directed against endotoxin--has the time come?
    Quezado ZM; Hoffman WD
    West J Med; 1993 Apr; 158(4):424-5. PubMed ID: 8317138
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to tumour necrosis factor in the treatment of severe sepsis: rationale and early clinical experience.
    Cohen J
    Prog Clin Biol Res; 1991; 367():187-96. PubMed ID: 1924427
    [No Abstract]   [Full Text] [Related]  

  • 14. Cure of chronic prostatitis presumably due to Enterococcus spp and gram-negative bacteria.
    Pronk MJ; Pelger RC; Baranski AG; van Dam A; Arend SM
    Eur J Clin Microbiol Infect Dis; 2006 Apr; 25(4):270-1. PubMed ID: 16583186
    [No Abstract]   [Full Text] [Related]  

  • 15. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary artery catheterisation in septic shock. Indications; therapeutic and prognostic implications.
    Groeneveld AB; Thijs LG
    Clin Intensive Care; 1990; 1(3):111-5. PubMed ID: 10149073
    [No Abstract]   [Full Text] [Related]  

  • 17. Vertebral osteomyelitis.
    Jaramillo-de la Torre JJ; Bohinski RJ; Kuntz C
    Neurosurg Clin N Am; 2006 Jul; 17(3):339-51, vii. PubMed ID: 16876033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of Pediatric Community-acquired Bacterial Pneumonia.
    Messinger AI; Kupfer O; Hurst A; Parker S
    Pediatr Rev; 2017 Sep; 38(9):394-409. PubMed ID: 28864731
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of Endotoxin Adsorption in Two Swedish Patients with Septic Shock.
    Broman ME; Bodelsson M
    Blood Purif; 2019; 47 Suppl 3():1-3. PubMed ID: 30982027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.